Coronary heart disease CT: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Coronary heart disease}} | {{Coronary heart disease}} | ||
The role of coronary computed tomographic angiography ( | The role of coronary computed tomographic angiography (CCTA) versus functional testing is not clear: | ||
* The SCOT-HEART trial in 2015 did not find clear statistical evidence of benefit anlthought there was a trend towards less cardiac outcomes among patients who received CTA<ref name="pmid25788230">{{cite journal| author=SCOT-HEART investigators| title=CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. | journal=Lancet | year= 2015 | volume= 385 | issue= 9985 | pages= 2383-91 | pmid=25788230 | doi=10.1016/S0140-6736(15)60291-4 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25788230 }} </ref><ref name="pmid25773919">{{cite journal| author=Douglas PS, Hoffmann U, Patel MR, Mark DB, Al-Khalidi HR, Cavanaugh B et al.| title=Outcomes of anatomical versus functional testing for coronary artery disease. | journal=N Engl J Med | year= 2015 | volume= 372 | issue= 14 | pages= 1291-300 | pmid=25773919 | doi=10.1056/NEJMoa1415516 | pmc=PMC4473773 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25773919 }} [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26109577 Review in: Evid Based Med. 2015 Aug;20(4):145] [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26280433 Review in: Ann Intern Med. 2015 Aug 18;163(4):JC11] </ref> | |||
* The PROMISE trial in 2015 did not find benefit<ref name="pmid25773919">{{cite journal| author=Douglas PS, Hoffmann U, Patel MR, Mark DB, Al-Khalidi HR, Cavanaugh B | display-authors=etal| title=Outcomes of anatomical versus functional testing for coronary artery disease. | journal=N Engl J Med | year= 2015 | volume= 372 | issue= 14 | pages= 1291-300 | pmid=25773919 | doi=10.1056/NEJMoa1415516 | pmc=4473773 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25773919 }} [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=&cmd=prlinks&id=26109577 Review in: Evid Based Med. 2015 Aug;20(4):145] [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=&cmd=prlinks&id=26280433 Review in: Ann Intern Med. 2015 Aug 18;163(4):JC11] </ref> | |||
* A meta-analysis in 2018 that included the SCOT-HEART and PROMISE trials found not benefit<ref name="pmid29467161">{{cite journal| author=Siontis GC, Mavridis D, Greenwood JP, Coles B, Nikolakopoulou A, Jüni P | display-authors=etal| title=Outcomes of non-invasive diagnostic modalities for the detection of coronary artery disease: network meta-analysis of diagnostic randomised controlled trials. | journal=BMJ | year= 2018 | volume= 360 | issue= | pages= k504 | pmid=29467161 | doi=10.1136/bmj.k504 | pmc=5820645 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29467161 }} </ref> | |||
* Subsequent publication of longer term follow-up of the SCOT-HEART trial found cardiac benefit<ref name="pmid30145934">{{cite journal| author=SCOT-HEART Investigators. Newby DE, Adamson PD, Berry C, Boon NA, Dweck MR | display-authors=etal| title=Coronary CT Angiography and 5-Year Risk of Myocardial Infarction. | journal=N Engl J Med | year= 2018 | volume= 379 | issue= 10 | pages= 924-933 | pmid=30145934 | doi=10.1056/NEJMoa1805971 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30145934 }} [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=&cmd=prlinks&id=30557423 Review in: Ann Intern Med. 2018 Dec 18;169(12):JC70] </ref> | |||
CCTA may best benefit patients with intermediate risk<ref name="pmid31547994">{{cite journal| author=Han D, Beecy A, Anchouche K, Gransar H, Dunham PC, Lee JH | display-authors=etal| title=Risk Reclassification With Coronary Computed Tomography Angiography-Visualized Nonobstructive Coronary Artery Disease According to 2018 American College of Cardiology/American Heart Association Cholesterol Guidelines (from the Coronary Computed Tomography Angiography Evaluation for Clinical Outcomes : An International Multicenter Registry [CONFIRM]). | journal=Am J Cardiol | year= 2019 | volume= 124 | issue= 9 | pages= 1397-1405 | pmid=31547994 | doi=10.1016/j.amjcard.2019.07.045 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31547994 }} </ref>. | |||
==References== | ==References== |
Revision as of 17:16, 13 May 2020
Coronary heart disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Coronary heart disease CT On the Web |
American Roentgen Ray Society Images of Coronary heart disease CT |
Risk calculators and risk factors for Coronary heart disease CT |
The role of coronary computed tomographic angiography (CCTA) versus functional testing is not clear:
- The SCOT-HEART trial in 2015 did not find clear statistical evidence of benefit anlthought there was a trend towards less cardiac outcomes among patients who received CTA[1][2]
- The PROMISE trial in 2015 did not find benefit[2]
- A meta-analysis in 2018 that included the SCOT-HEART and PROMISE trials found not benefit[3]
- Subsequent publication of longer term follow-up of the SCOT-HEART trial found cardiac benefit[4]
CCTA may best benefit patients with intermediate risk[5].
References
- ↑ SCOT-HEART investigators (2015). "CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial". Lancet. 385 (9985): 2383–91. doi:10.1016/S0140-6736(15)60291-4. PMID 25788230.
- ↑ 2.0 2.1 Douglas PS, Hoffmann U, Patel MR, Mark DB, Al-Khalidi HR, Cavanaugh B; et al. (2015). "Outcomes of anatomical versus functional testing for coronary artery disease". N Engl J Med. 372 (14): 1291–300. doi:10.1056/NEJMoa1415516. PMC 4473773. PMID 25773919. Review in: Evid Based Med. 2015 Aug;20(4):145 Review in: Ann Intern Med. 2015 Aug 18;163(4):JC11
- ↑ Siontis GC, Mavridis D, Greenwood JP, Coles B, Nikolakopoulou A, Jüni P; et al. (2018). "Outcomes of non-invasive diagnostic modalities for the detection of coronary artery disease: network meta-analysis of diagnostic randomised controlled trials". BMJ. 360: k504. doi:10.1136/bmj.k504. PMC 5820645. PMID 29467161.
- ↑ SCOT-HEART Investigators. Newby DE, Adamson PD, Berry C, Boon NA, Dweck MR; et al. (2018). "Coronary CT Angiography and 5-Year Risk of Myocardial Infarction". N Engl J Med. 379 (10): 924–933. doi:10.1056/NEJMoa1805971. PMID 30145934. Review in: Ann Intern Med. 2018 Dec 18;169(12):JC70
- ↑ Han D, Beecy A, Anchouche K, Gransar H, Dunham PC, Lee JH; et al. (2019). "Risk Reclassification With Coronary Computed Tomography Angiography-Visualized Nonobstructive Coronary Artery Disease According to 2018 American College of Cardiology/American Heart Association Cholesterol Guidelines (from the Coronary Computed Tomography Angiography Evaluation for Clinical Outcomes : An International Multicenter Registry [CONFIRM])". Am J Cardiol. 124 (9): 1397–1405. doi:10.1016/j.amjcard.2019.07.045. PMID 31547994.